Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04907305 · ClinicalTrials.gov registry record
Next-Gen MS: Feed-forward PRO Data for MS Research
A clinical trial, sponsored by EMD Serono Research & Development Institute.
- Terminated
- Registry status
- 1,594
- Enrollment target
NCT04907305 is a clinical trial that was terminated before completion, run by EMD Serono Research & Development Institute. The registered enrollment target is 1,594 participants.
The verdict
NCT04907305 was terminated before completion, sponsored by EMD Serono Research & Development Institute.
- TERMINATED
- Registry status
- 1,594 participants
- Enrollment target
Study Summary
This Next Generation learning health system for Multiple Sclerosis (Next-Gen MS) study is a sub-study of the MS-LINK™ Outcomes Study (NCT04735406). The study aims to examine the effects of using feed forward Patient Reported Outcomes (PROs) data in real-world Multiple Sclerosis (MS) care settings. The study will be conducted within an emerging Learning Healthcare System (LHS).
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,594 participants |
| Start Date | 2021-11-02 |
| Est. Completion | 2024-02-19 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04907305
The ClinicalTrials.gov registry entry for NCT04907305 describes a study currently listed as terminated, categorized as an unspecified phase. The registered enrollment target is 1,594 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is EMD Serono Research & Development Institute, which has 81 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT04907305 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04907305 about?
NCT04907305 is a clinical study titled "Next-Gen MS: Feed-forward PRO Data for MS Research". This Next Generation learning health system for Multiple Sclerosis (Next-Gen MS) study is a sub-study of the MS-LINK™ Outcomes Study (NCT04735406). The study aims to examine the effects of using feed forward Patient Reported Outcomes (PROs) data in real-world Multiple Sclerosis (MS) care settings. T...
What is the current status of trial NCT04907305?
This trial is currently terminated. The enrollment target is 1,594 participants. The study started on 2021-11-02. Estimated completion is 2024-02-19.
Who is sponsoring clinical trial NCT04907305?
This trial is sponsored by EMD Serono Research & Development Institute, which has 81 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.